Entropy Technologies LP Takes Position in Cardinal Health, Inc. $CAH

Entropy Technologies LP acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 18,511 shares of the company’s stock, valued at approximately $3,912,000.

Several other institutional investors also recently bought and sold shares of CAH. Kornitzer Capital Management Inc. KS grew its stake in shares of Cardinal Health by 100.8% during the 4th quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock worth $3,733,000 after purchasing an additional 9,120 shares during the period. HF Advisory Group LLC lifted its stake in Cardinal Health by 97.5% in the 4th quarter. HF Advisory Group LLC now owns 10,227 shares of the company’s stock valued at $2,102,000 after buying an additional 5,049 shares in the last quarter. Abacus FCF Advisors LLC acquired a new stake in shares of Cardinal Health in the fourth quarter worth approximately $7,182,000. Byrne Financial Freedom LLC acquired a new stake in Cardinal Health during the 4th quarter worth $1,574,000. Finally, Belleair Asset Management LLC acquired a new position in Cardinal Health during the fourth quarter worth about $1,100,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.9%

Shares of NYSE:CAH opened at $227.96 on Friday. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $243.21. The company’s 50 day moving average is $219.98 and its two-hundred day moving average is $214.43. The company has a market cap of $53.39 billion, a PE ratio of 34.86, a P/E/G ratio of 1.12 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the prior year, the business posted $2.35 EPS. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were given a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s payout ratio is currently 31.50%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Evercore dropped their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a report on Wednesday, April 8th. Mizuho boosted their price objective on shares of Cardinal Health from $235.00 to $240.00 and gave the company an “outperform” rating in a report on Thursday. Zacks Research lowered shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Citigroup lifted their price target on shares of Cardinal Health from $245.00 to $265.00 and gave the company a “buy” rating in a research report on Friday. Finally, Bank of America boosted their price objective on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $251.73.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.